Letter to the editor: Comment on “HepatoScore‐14: Measures of biological heterogeneity significantly improve prediction of hepatocellular carcinoma risk”

We have read with great interest the article published in Hepatology by Jeffrey S. Morris et al(1). The authors carried out a retrospective study including 767 patients with hepatocellular carcinoma (HCC) and 200 healthy individuals as a control group to comprehensively construct a risk score from circulating biomarkers, and predict survival in HCC patients.